Transcranial brain parenchyma sonographic findings in patients with myotonic dystrophy type 1 and 2

Transcranial brain parenchyma sonographic findings in patients with myotonic dystrophy type 1 and 2

Introduction: Myotonic dystrophy type 1 (DM1) and 2 (DM2) are genetically determined progressive muscular disorders with multisystemic affection, including brain involvement. Transcranial sonography (TCS) is a reliable diagnostic tool for the investigation of deep brain structures. We sought to eval...

Full description

Bibliographic Details
Main Authors:	Milija Mijajlovic, Ivo Bozovic, Aleksandra Pavlovic, Vidosava Rakocevic-Stojanovic, Sanja Gluscevic, Amalija Stojanovic, Ivana Basta, Giovanni Meola, Stojan Peric
Format:	Article
Language:	English
Published:	Elsevier 2024-03-01
Series:	Heliyon
Subjects:	Myotonic dystrophy type 1 Myotonic dystrophy type 2 Transcranial sonography Substantia nigra Nucleus raphe
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844024028871

Similar Items

Development of Therapeutic Approaches for Myotonic Dystrophies Type 1 and Type 2
by: Lubov Timchenko
Published: (2022-09-01)

Editorial: Myotonic Dystrophies: Developments in Research From Bench to Bedside
by: Gabriella Silvestri, et al.
Published: (2020-09-01)

A Patient with Myotonic Dystrophy Type 1 Presenting as Parkinsonism
by: Ji-Hyun Choi, et al.
Published: (2018-09-01)

Recent Progress and Challenges in the Development of Antisense Therapies for Myotonic Dystrophy Type 1
by: Thiéry De Serres-Bérard, et al.
Published: (2022-11-01)

Molecular and Clinical Implications of Variant Repeats in Myotonic Dystrophy Type 1
by: Stojan Peric, et al.
Published: (2021-12-01)

Repeat Interruptions Modify Age at Onset in Myotonic Dystrophy Type 1 by Stabilizing DMPK Expansions in Somatic Cells
by: Jovan Pešović, et al.
Published: (2018-11-01)

Deciphering the mechanisms underlying brain alterations and cognitive impairment in congenital myotonic dystrophy
by: Thiéry De Serres-Bérard, et al.
Published: (2021-12-01)

Autoimmune Diseases in Patients With Myotonic Dystrophy Type 2
by: Stojan Peric, et al.
Published: (2022-07-01)

Anesthesia for a Patient with Myotonic Dystrophy
by: Dilek Kalaycı, et al.
Published: (2016-09-01)

Molecular genetics of congenital myotonic dystrophy
by: Stella Lanni, et al.
Published: (2019-12-01)

A Greek National Cross-Sectional Study on Myotonic Dystrophies
by: Georgios K. Papadimas, et al.
Published: (2022-12-01)

Myotonic Dystrophy Type 1 with Syringomyelia in a Young Patient
by: Xiao-Lin Yu, et al.
Published: (2016-01-01)

Anesthetic Management for Multiple Family Members with Myotonic Dystrophy for Interventional Cardiac Procedures—A Case Series
by: Leonid Gorelik, et al.
Published: (2018-01-01)

Clinical and Molecular Insights into Gastrointestinal Dysfunction in Myotonic Dystrophy Types 1 & 2
by: Janel A. M. Peterson, et al.
Published: (2022-11-01)

Electrodiagnostic findings in myotonic dystrophy: A study on 12 patients
by: Ahmet S. Burakgazi
Published: (2019-12-01)

Mitigating RNA Toxicity in Myotonic Dystrophy using Small Molecules
by: Kaalak Reddy, et al.
Published: (2019-08-01)

Two cases of myotonic dystrophy manifesting various ophthalmic findings with genetic evaluation
by: Min Ji Kang, et al.
Published: (2016-01-01)

Thymoma-associated myasthenia gravis coexisting with myotonic dystrophy: a case report
by: Michiyo Miyawaki, et al.
Published: (2021-07-01)

Pattern retinal dystrophy in a case of myotonic dystrophy
by: Chahveer Singh Bindra, et al.
Published: (2023-01-01)

Myotonic Dystrophies: A Genetic Overview
by: Payam Soltanzadeh
Published: (2022-02-01)

Desflurane anaesthesia in myotonic dystrophy
by: Ranju Gandhi, et al.
Published: (2011-01-01)

Inhibition of Postn Rescues Myogenesis Defects in Myotonic Dystrophy Type 1 Myoblast Model
by: Xiaopeng Shen, et al.
Published: (2021-08-01)

Fundus flavimaculatus-like in myotonic dystrophy: a case report
by: Eric Kirkegaard-Biosca, et al.
Published: (2021-05-01)

Skeletal muscle features in myotonic dystrophy and sarcopenia: do similar nuclear mechanisms lead to skeletal muscle wasting?
by: M. Malatesta
Published: (2012-08-01)

Targeting Myotonic Dystrophy Type 1 with Metformin
by: Mikel García-Puga, et al.
Published: (2022-03-01)

Myotonic dystrophy type 1: one case report
by: WU Xu⁃ling, et al.
Published: (2023-08-01)

Targeting DMPK with Antisense Oligonucleotide Improves Muscle Strength in Myotonic Dystrophy Type 1 Mice
by: Dominic Jauvin, et al.
Published: (2017-06-01)

Characterization of Iron Accumulation in Deep Gray Matter in Myotonic Dystrophy Type 1 and 2 Using Quantitative Susceptibility Mapping and R2* Relaxometry: A Magnetic Resonance Imaging Study at 3 Tesla
by: Sevda Ates, et al.
Published: (2019-12-01)

Coexistence of Myotonic Dystrophy and Normal Pressure Hydrocephaly: Causative or Incidental?
by: Ebru Barcın, et al.
Published: (2013-06-01)

The Biomarker Potential of miRNAs in Myotonic Dystrophy Type I
by: Emma Koehorst, et al.
Published: (2020-12-01)

Sigmoid Volvulus in Myotonic Dystrophy Type I (Steinert Disease)
by: Ahmed B. Bayoumy, et al.
Published: (2022-03-01)

Healthcare resource utilization, total costs, and comorbidities among patients with myotonic dystrophy using U.S. insurance claims data from 2012 to 2019
by: Sarah J. Howe, et al.
Published: (2022-02-01)

Small Molecules Which Improve Pathogenesis of Myotonic Dystrophy Type 1
by: Marta López-Morató, et al.
Published: (2018-05-01)

Structural myocardial involvement in adult patients with type 1 myotonic dystrophy
by: Upinder K. Dhand, et al.
Published: (2013-03-01)

Perceived fatigue in myotonic dystrophy type 1: a case-control study
by: Stefan Winblad, et al.
Published: (2019-03-01)

Therapeutic Targeting of the GSK3β-CUGBP1 Pathway in Myotonic Dystrophy
by: Maggie Lutz, et al.
Published: (2023-06-01)

Cardiac Manifestations of Myotonic Dystrophy in a Pediatric Cohort
by: Laia Brunet Garcia, et al.
Published: (2022-06-01)

Factors Influencing the Severity and Progression of Respiratory Muscle Dysfunction in Myotonic Dystrophy Type 1
by: Leigh Hartog, et al.
Published: (2021-04-01)

Relationship of white and gray matter abnormalities to clinical and genetic features in myotonic dystrophy type 1
by: Stefano Zanigni, et al.
Published: (2016-01-01)

Premature senescence in primary muscle cultures of myotonic dystrophy type 2 is not associated with p16 induction
by: L.V. Renna, et al.
Published: (2014-10-01)